Table 1.
Clinical demographics.
ID | Sex | Age of death | Duration from HIV diagnosis | ART | Clinical diagnoses |
---|---|---|---|---|---|
LG05 | M | 57 | 23 | TAF/FTC/RPV+DTG | ALS |
LG14 | M | 59 | 15 | FTC/TAF+DTG | SCC of the tongue |
LG15 | M | 88 | 26 | 3TC+DTG | Multiple medical comorbidities |
Abbreviations: TAF, tenofovir alafenamide (NRTI); FTC, emtricitabine (NRTI), RPV, rilpivirine (NNRTI); DTG, dolutegravir (INSTI); 3TC, lamivudine (NRTI); NRTI, nucleoside/nucleotide reverse transcriptase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitors; INSTI, integrase inhibitors; ALS, amyotrophic lateral sclerosis; SCC, squamous cell cancer; ART, antiretroviral therapy.